Karman Stock: 5 Straight Red Days, Down 14%
A five-day slide in Karman stock puts the focus on a business with rapid growth but a very high valuation.
Karman (KRMN) stock has fallen 14% over its last five trading sessions. The stock has now moved lower for 5 consecutive trading days, a slide that has erased about $1.1 billion from the company’s market value.
For anyone holding the shares, the company’s market capitalization now stands at about $7.1 billion. The sudden drop reverses a recent rebound—the stock had gained 7.4% over the prior month—and leaves its trailing three-month return at -18.2% once the current slide is factored in.
The Streak Next To The S&P 500
- 10 Green Days In A Row: Imperial Oil Stock Is Up 10%
- How Will Five Below Stock React To Its Upcoming Earnings?
- How Will Williams-Sonoma Stock React To Its Upcoming Earnings?
- Corcept Therapeutics Stock Climbs 11% On A 6-Day Winning Streak
- Forgent Power Solutions Stock: 5 Straight Red Days, Down 16%
- The 52-Week-High List: 20 S&P 500 Names On Friday
Here is how KRMN stock stacks up against the S&P 500 over the streak and the periods around it:
| Return Period | KRMN | S&P 500 |
|---|---|---|
| 1D | -1.8% | 0.4% |
| 5D (Current Streak) | -13.9% | -1.4% |
| 1M (21D) | 7.4% | 3.6% |
| 3M (63D) | -18.2% | 3.1% |
| YTD 2026 | -27.0% | 12.1% |
| 2025 | 16.4% | |
| 2024 | 23.3% | |
| 2023 | 24.2% |
What’s Behind The Stock’s Recent Weakness?
The decline is specific to Karman, trailing the S&P 500’s -1.4% return over the same window. With no company-specific negative news or guidance changes, the pullback appears to reflect natural profit-taking following a 28% rally across seven straight green sessions.
On one hand, revenue over the last twelve months grew 50.2%, far outpacing the S&P 500 median revenue growth of 8.4%. On the other hand, its operating margin of 16.8% is slightly below the S&P 500 median of 18.4%. The stock also trades at a price-to-earnings multiple of 190.3, a significant premium to the S&P 500 median of 23.2.
How Should An Investor Interpret A Streak?
A streak is a piece of information, not an instruction to act. It tells you that a stock has momentum and has captured the market’s attention, but it doesn’t say whether the new price is fair. Over the trailing twelve months, the stock has returned +5.2%.
The disciplined response is to use the new price as a prompt to re-evaluate the business. The data here provides a starting point: a high-growth company with a premium valuation that is facing a period of negative sentiment.
If the drop has you weighing an entry, resist buying a falling price alone. Our Buy the Dip screen ranks the marked-down names where growth and cash generation still support a recovery.
Prefer the theme to this single name? Our ETF Scorecard shows how the aerospace & defense funds stack up. It is still a concentrated bet on that one theme, though, which is exactly the gap the portfolio below closes.
Falling Prices Test Conviction. Rules Do Not Flinch
A losing streak forces a choice on every holder: sell into weakness, average down, or freeze. All three are emotional answers to what should be an analytical question, and emotions priced at market open are expensive.
The Trefis High Quality (HQ) Portfolio takes the emotion out: about 30 quality businesses screened for the fundamentals that survive bad stretches, held and rebalanced by rules. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Let the rules do the flinching for you.